Cumberland Pharmaceuticals, Inc. (CPIX) Reports In-Line Q1 EPS

Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX) reported Q1 EPS of $0.05, in-line with the analyst estimate of $0.05. Revenue for the quarter came in at $10.3 million versus the consensus estimate of $10 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals, Inc. (CPIX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Apple Touched $5 Trillion and Then Gave It Back. Gabriel Adams, Senior Markets Strategist at Swiftvale, on Reading a Milestone and a Reversal in the Same Week
• European shares tick higher as easing Fed hike bets lift gold